Intestinal permeability and faecal granulocyte marker protein in dextran sulphate sodium - Induced colitis in rats

Scandinavian Journal of Laboratory Animal Science

Volumn 30, Issue 4, 2003, Pages 169-175

  Milde, Anne Marita ^a   Arslan, Gülen ^b   Røeth, Arne ^c   Berstad, Arnold ^b   Overmier, J Bruce ^d   Murison, Robert ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPROTECTIN; DEXTRAN SULFATE; DRINKING WATER; EDETATE CHROMIUM CR 51;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; FECES ANALYSIS; FLUID INTAKE; GRANULOCYTE; INTESTINE MUCOSA PERMEABILITY; MALE; MOLECULAR WEIGHT; NONHUMAN; RADIOACTIVITY; RAT; RODENT DISEASE; STATISTICAL ANALYSIS; URINALYSIS; URINARY EXCRETION;

ANIMALIA; RODENTIA;

EID: 0346656894     PISSN: 09013393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Araki Y, A Andoh, Y Fujiyama & T Bamba: Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clinical Experimental Immunology, 2000, 119, 264-269.
2. 51CrEDTA colonic permeability and therapy response in patients with ulcerative colitis. Nuclear Medicine Communications, 2001, 22, 997-1001.
3. Berstad A, G Arslan & G Folvik G: Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scandinavian Journal of Gastroenterology, 2000, 35, 64-69, 2000.
4. Elson CO, RB Sartor, GS Tennyson & RH Riddell: Experimental models of inflammatory bowel disease. Gastroenterology, 1995, 109, 1344-1367.
5. Gaudio E, G Taddei, A Vetuschi, R Sferra, G Frieri, G Ricciardi & R Caprilli: Dextran sulfate sodium (DSS) colitis in rats. Clinical, structural and ultrastructural aspects. Digestive Diseases and Sciences, 1999, 44(7), 1458-1475.
6. 51Cr-EDTA in patients with active inflammatory bowel disease. Clinical and Investigative Medicine, 1988, 11(2), 151-155.
7. Kristinsson J, AG Røseth, K Sundset, K Nygaard, EM Løberg, JE Paulsen & E Aadland: Granulocyte marker protein is increased in stools from rats with azoxymethane-induced colon cancer. Scandinavian Journal of Gastroenterology, 1999, 34, 1216-1223.
8. Mahmud T, S Somasundaram, G Sigthorsson, RJ Simpson, S Rafi, R Foster, IA Tavares, A Røseth, AJ Hutt, M Jacob, J Pacy & DL Scott, JM Wrigglesworth & L Bjarnason: Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat. Gut, 1998, 43, 775-782.
9. Milde AM & R Murison: A study of the effects of restraint stress on colitis induced by dextran sulphate sodium in singly housed rats. Integrative Physiological & Behavioral Science, 2002, 37, 140-150.
10. Røseth AG, PN Schmidt & MK Fagerhol: Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 1999, 34, 50-54.
11. Thomas YM: Intestinal epithelial barrier dysfunction in Crohn's disease. Proceedings of the Society for the Experimental Biology and Medicine, 1997, 214, 318-327.
12. Tibble JA, G Sigthorsson, S Bridger, MK Fagerhol & I Bjarnason: Surrogate markers of intestinal inflammation are predicitive of relapse in patients with inflammatory bowel disease. Gastroenterology, 2000, 119, 15-22.
13. Venkatraman A, BS Ramakrishna, AB Pulimood, S Patra & S Murthy: Increased permeability in dextran sulphate colitis in rats: Time course of development and effect of butyrate. Scandinavian Journal of Gastroenterology, 2000, 35, 1053-1059.
14. Wallace JL & CM Keenan: An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. American Journal of Physiology, 1990, 258, 527-534.
15. Willoughby RP, KA Harris, MW Carson, CM Martin, M Troster, G DeRose, WG Jamieson & RF Potter: Intestinal mucosal permeability to 51Cr-ethylenediaminetetraacetic acid is increased after bilateral lower extremity ischemia-reperfusion in the rat. Surgery, 1996, 120, 547-553.